Article
Bisdemethoxycurcumin, a novel potent polyphenolic compound, effectively inhibits the formation of amyloid aggregates in ALS-associated hSOD1 mutant (L38R).
International journal of biological macromolecules - 1 Dec 2024
Kouhi Zeinab Haghgoo, Seyedalipour Bagher, Hosseinkhani Saman, Chaichi Mohammad Javad
Abstract excerpt
Protein misfolding is a biological process that leads to protein aggregation. Anomalous misfolding and aggregation of human superoxide dismutase (hSOD1) into amyloid aggregates is a characteristic feature of amyotrophic lateral sclerosis (ALS), a neurodegenerative illness. Thus, focusing on the L38R mutant may be a wise decision to comprehend the SOD1 disease process in ALS. We suggest that Bisdemethoxycurcumin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
